Pipeline Depth Underpinned by Multiple Indications and Platforms Invectys Inc. develops a full range of innovative and very promising immunotherapeutic oncology…
HLA-G: from pregnancy to tumors Invectys Inc. targets a powerful immune checkpoint named HLA-G. HLA-G is a non-classical MHC class I molecule normally only expressed…
A DNA vaccine targeting a specific cancer marker Cancer cells produce an enzyme which is key to their unlimited proliferation, but is nearly never expressed in normal…
Using specific cancer markers to turn “cold” tumors “hot” Cells will express on their surface short protein fragments – peptides – corresponding to proteins…
